Biofabrication of a PLGA-TCP-based porous bioactive bone substitute with sustained release of icaritin

Journal of Tissue Engineering and Regenerative Medicine

Volumn 9, Issue 8, 2015, Pages 961-972

  Xie, Xin Hui ^a,c   Wang, Xin Luan ^a,b   Zhang, Ge ^a   He, Yi Xin ^a   Leng, Yang ^d   Tang, Ting Ting ^e   Pan, Xiaohua ^f   Qin, Ling ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

Biocompatibility; Cytotoxicity; Icaritin; Osteogenesis; Poly(l lactide co glycolide) tricalcium phosphate; Scaffold

Indexed keywords

BIOMECHANICS; BONE; CELL CULTURE; COMPRESSION TESTING; COMPUTERIZED TOMOGRAPHY; CYTOTOXICITY; SCAFFOLDS; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; STEM CELLS; TRANSMISSION CONTROL PROTOCOL; WATER ABSORPTION;

COMPOSITE SCAFFOLDS; GLYCOLIDE; ICARITIN; IN-VITRO; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; POLY (L-LACTIDE); POLY(L-LACTIDE-CO-GLYCOLIDE)/TRICALCIUM PHOSPHATE; SUSTAINED RELEASE; TRI-CALCIUM PHOSPHATES;

BIOCOMPATIBILITY;

CALCIUM PHOSPHATE; ICARITIN; PLANT MEDICINAL PRODUCT; POLYGLACTIN; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE; BIOMATERIAL; BONE PROSTHESIS; DELAYED RELEASE FORMULATION; FLAVONOID; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIOMINERALIZATION; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE PROSTHESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COMPOSITE MATERIAL; COMPRESSION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; NEW ZEALAND WHITE (RABBIT); NONHUMAN; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; TISSUE SCAFFOLD; WATER ABSORPTION; YOUNG MODULUS; ANIMAL; BONE; BONE MARROW CELL; CHEMISTRY; CYTOLOGY; DELAYED RELEASE FORMULATION; HUMAN; MECHANICAL STRESS; MESENCHYMAL STROMA CELL; MOUSE; PATHOLOGY; PROCEDURES; RABBIT; SURFACE PROPERTY; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MARROW CELLS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; FLAVONOIDS; HUMANS; LACTIC ACID; MESENCHYMAL STROMAL CELLS; MICE; POLYGLYCOLIC ACID; POROSITY; RABBITS; STRESS, MECHANICAL; SURFACE PROPERTIES; TISSUE ENGINEERING; WATER; X-RAY MICROTOMOGRAPHY;

EID: 84938743988     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1679     Document Type: Article

References (52)

1. Cancedda R, Giannoni P, Mastrogiacomo M. 2007; A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28(29): 4240-4250.
2. Chen SH, Wang XL, Xie XH, et al. 2012; Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study. Acta Biomater 8: 3128-3137.
3. Ehrenfried LM, Patel MH, Cameron RE. 2008; The effect of tricalcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA). J Mater Sci Mater Med 19(1): 459-466.
4. Giesen EB, Ding M, Dalstra M, et al. 2001; Mechanical properties of cancellous bone in the human mandibular condyle are anisotropic. J Biomech 34(6): 799-803.
5. Guan L, Davies JE. 2004; Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold. J Biomed Mater Res A 71(3): 480-487.
6. Hao W, Hu YY, Wei YY, et al. 2008; Collagen I gel can facilitate homogeneous bone formation of adipose-derived stem cells in PLGA-β-TCP scaffold. Cells Tissues Organs 187(2): 89-102.
7. He K, Wang XL, Kumta SM, et al. 2009; Fabrication of a two-level tumor bone repair biomaterial based on a rapid prototyping technique. Biofabrication 1(2): 025003.
8. Hench LL, Polak JM. 2002; Third-generation biomedical materials. Science 295(5557): 1014-1017.
9. Huang J, Yuan L, Wang X, et al. 2007; Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci 81(10): 832-840.
10. Hungerford DS. 2007; Treatment of osteonecrosis of the femoral head: everything's new. J Arthroplasty 22(4, suppl 1): 91-94.
11. Ignatius AA, Claes LE. 1996; In vitro biocompatibility of bioresorbable polymers: poly(l, dl-lactide) and poly(l-lactide-co-glycolide). Biomaterials 17(8): 831-839.
12. Ignjatovic N, Ninkov P, Kojic V, et al. 2006; Cytotoxicity and fibroblast properties during in vitro test of biphasic calcium phosphate/poly-dl-lactide-co-glycolide biocomposites and different phosphate materials. Microsc Res Tech 69(12): 976-982.
13. Ivirico JL, Salmeron-Sanchez M, Ribelles JL, et al. 2009; Proliferation and differentiation of goat bone marrow stromal cells in 3D scaffolds with tunable hydrophilicity. J Biomed Mater Res B Appl Biomater 91(1): 277-286.
14. Kanczler JM, Oreffo RO. 2008; Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15: 100-114.
15. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26(27): 5474-5491.
16. Komlev VS, Mastrogiacomo M, Pereira RC, et al. 2010; Biodegradation of porous calcium phosphate scaffolds in an ectopic bone formation model studied by X-ray computed microtomograph. Eur Cell Mater 19: 136-146.
17. Kruyt MC, de Bruijn JD, Wilson CE, et al. 2003; Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 9(2): 327-336.
18. Lalik E, Mirek R, Rakoczy J, et al. 2006; Microcalorimetric study of sorption of water and ethanol in zeolites 3A and 5A. Catal Today 114(2-3): 242-247.
19. Lee JH, Oh JH, Lee JH, et al. 2011; Evaluation of in vitro spermatogenesis using poly(d, l-lactic-co-glycolic acid; PLGA)-based macroporous biodegradable scaffolds. J Tissue Eng Regen Med 5(2): 130-137.
20. Levi B, James AW, Nelson ER, et al. 2011; Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 5(6): e11177.
21. Lu HH, El-Amin SF, Scott KD, et al. 2003; Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro. J Biomed Mater Res A 64(3): 465-474.
22. Nie H, Soh BW, Fu YC, et al. 2008; Three-dimensional fibrous PLGA/HAp composite scaffold for BMP-2 delivery. Biotechnol Bioeng 99(1): 223-234.
23. Ninin E, Milpied N, Moreau P, et al. 2001; Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33(1): 41-47.
24. Nishida J, Shimamura T. 2008; Methods of reconstruction for bone defect after tumor excision: a review of alternatives. Med Sci Monit 14(8): RA107-113.
25. Qin L, Zhang G, Sheng H, et al. 2008; Phytoestrogenic compounds for prevention of steroid-associated osteonecrosis. J Musculoskelet Neuronal Interact 8(1): 18-21.
26. Rezwan K, Chen QZ, Blaker JJ, et al. 2006; Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27(18): 3413-3431.
27. Satturwar PM, Fulzele SV, Dorle AK. 2003; Biodegradation and in vivo biocompatibility of rosin: a natural film-forming polymer. AAPS Pharm Sci Tech 4(4): E55.
28. Shen P, Wong SP, Yong EL. 2007; Sensitive and rapid method to quantify icaritin and desmethylicaritin in human serum using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 857(1): 47-52.
29. Sherwood JK, Riley SL, Palazzolo R, et al. 2002; A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials 23(24): 4739-4751.
30. Stevenson S, Shaffer JW, Goldberg VM. 1996; The humoral response to vascular and nonvascular allografts of bone. Clin Orthop Relat Res 326: 86-95.
31. Tang TT, Lu B, Yue B, et al. 2007; Treatment of osteonecrosis of the femoral head with hBMP-2 gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 89(1): 127-129.
32. Tohma Y, Ohgushi H, Morishita T, et al. 2008; Bone marrow-derived mesenchymal cells can rescue the osteogenic capacity of devitalized autologous bone. J Tissue Eng Regen Med 2(1): 61-68.
33. Van der Zande M, Walboomers XF, Olalde B, et al. 2011; Effect of nanotubes and apatite on growth factor release from PLLA scaffolds. J Tissue Eng Regen Med 5(6): 476-482.
34. Velayudhan S, Anilkumar TV, Kumary TV, et al. 2005; Biological evaluation of pliable hydroxyapatite-ethylene vinyl acetate co-polymer composites intended for cranioplasty. Acta Biomater 1(2): 201-209.
35. Wang X, Ma J, Wang Y, et al. 2001; Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials 22(16): 2247-2255.
36. Wang X, Yan Y, Pan Y, et al. 2006; Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng 12(1): 83-90.
37. Wang X, Yan Y, Zhang R. 2007a; Rapid prototyping as a tool for manufacturing bioartificial livers. Trends Biotechnol 25(11): 505-513.
38. Wang XL, Zhang G, Wang NL, et al. 2007b; Phytoestrogenic molecule icaritin: a novel selective estrogen receptor modulator developed for treatment of osteoporosis. In International Osteoporosis Conference, Beijing, China.
39. Wang XL, Zhang G, Xie XH, et al. 2008; Antagonistic estrogen receptor-β signaling required in promoting periosteum bone formation and inhibiting osteoclastic bone resorption by icaritin - a novel synthetic small molecule. Bone 43(suppl 1): S115.
40. Woo BH, Fink BF, Page R, et al. 2001; Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 18(12): 1747-1753.
41. Xia Z, Huang Y, Adamopoulos IE, et al. 2006; Macrophage-mediated biodegradation of poly(dl-lactide-co-glycolide) in vitro. J Biomed Mater Res A 79(3): 582-590.
42. Xie XH, Zhang G, He YX, et al. 2009; Promotion of tissue repair of steroid-associated osteonecrosis lesion in rabbits by using PLGA/TCP/Icaritin composite biomaterials scaffold: an in vivo microcomputed tomography study. Bone 45(suppl 2): S107.
43. Yao D, Xie XH, Wang XL, et al. 2012; Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis - an in vitro efficacy study. PLoS One 7(8): e41264.
44. Yu D, Li Q, Mu X, et al. 2008; Bone regeneration of critical calvarial defect in goat model by PLGA/TCP/rhBMP-2 scaffolds prepared by low-temperature rapid-prototyping technology. Int J Oral Maxillofac Surg 37(10): 929-934.
45. Zein I, Hutmacher DW, Tan KC, et al. 2002; Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials 23(4): 1169-1185.
46. Zhang G, Guo BS, Wu H, et al. 2012; A delivery system targeting bone formation surface to facilitate RNAi-based bone anabolic therapy. Nat Med 18(2): 307-314.
47. Zhang G, Pan XH, Xie XH, et al. 2008; Icaritin, a potential estrogen receptor β-antagonist molecule, icaritin, promotes osteoporotic fracture repair in ovariectomized mice: preliminary finding at 3weeks post-fracture. Bone 43(suppl 1): s76-77.
48. Zhang G, Qin L, Sheng H, et al. 2009a; A novel semi-synthesized small molecule, icaritin, reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid deposition in a dose-dependent manner. Bone 44(2): 345-356.
49. Zhang G, Qin L, Sheng H, et al. 2007; Epimedium-derived phytoestrogen exerts beneficial effect on preventing steroid-associated osteonecrosis in rabbits with inhibition of both thrombosis and lipid-deposition. Bone 40(3): 685-692.
50. Zhang G, Wang XL, Sheng H, et al. 2009b; Constitutional flavonoids derived from Epimedium dose-dependently reduce incidence of steroid-associated osteonecrosis, not via direct action by themselves, on potential cellular targets. PLoS One 4(7): e6419.
51. Zhang R, Ma PX. 1999; Poly(α-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 44(4): 446-455.
52. Zhang YS, Li HZ, Zhang RQ, et al. 2005; [Preliminary research on preparation of porcine bladder acellular matrix graft for tissue engineering applications]. Zhonghua Yi Xue Za Zhi 85(38): 2724-2727.